Microarrays and Crohn's disease: Collecting reliable information

References

• Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999;21 Suppl 1:33–7.
   PubMed Web of Science ®Google Scholar
• Tilstone C. Vital statistics. Nature 2003;424:610–2.
   PubMed Web of Science ®Google Scholar
• Liu ET, Karuturi KR. Microarrays and clinical investigations. N Engl J Med 2004;350:1595–7.
   PubMed Web of Science ®Google Scholar
• Shaughnessy J Jr. Primer on medical genomics. Part IX: Scientific and clinical applications of DNA microarrays – multiple myeloma as a disease model. Mayo Clin Proc 2003; 78:1098–109.
   Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–11.
   PubMed Web of Science ®Google Scholar
• van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530–6.
   Google Scholar
• Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004;101:1039–44.
   PubMed Web of Science ®Google Scholar
• Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605–16.
   PubMed Web of Science ®Google Scholar
• Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617–28.
   Google Scholar
• Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol 2002;29:258–63.
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, et al. Molecular profiling of bladder cancer using cDNA microarrays:defining histogenesis and biological phenotypes. Cancer Res 2002;62:6973–80.
   Google Scholar
• Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003;301:1527–30.
   PubMedGoogle Scholar
• Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999;91:1758–64.
   PubMed Web of Science ®Google Scholar
• Huang Q, Dunn RT 2nd, Jayadev S, DiSorbo O, Pack FD, Farr SB, et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001;63:196–207.
   Google Scholar
• Ekins RP. Multi-analyte immunoassay. J Pharm Biomed Anal 1989;7:155–68.
   PubMed Web of Science ®Google Scholar
• Ekins RP, Chu F. Multispot, multianalyte immunoassay. The microanalytical “compact disk” of the future. Ann Biol Clin 1992;50:337–53.
   PubMed Web of Science ®Google Scholar
• Freeman WM, Robertson DJ, Vrana KE. Fundamentals of DNA hybridization arrays for gene expression analysis. BioTechniques 2000;29:1042–55.
   Google Scholar
• Lipshutz RJ, Fodot SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet 1999;21 Suppl 1:20–4.
   PubMedGoogle Scholar
• Bassett DE Jr, Eisen MB, Boguski MS. Gene expression informatics – it’s all in your mine. Nat Genet 1999;21 Suppl 1:51–5.
   PubMedGoogle Scholar
• Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet 1999;21 Suppl 1:10–4.
   PubMed Web of Science ®Google Scholar
• Li C, Wong WH. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31–6.
   PubMed Web of Science ®Google Scholar
• Arbeitman MN, Furlong EEM, Imam F, Johnson E, Null BH, Baker BS, et al. Gene expression during the life cycle of Drosophila melanogaster. Science 2002;297:2270–5.
   PubMed Web of Science ®Google Scholar
• Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, Storz G, et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 2000;11:4241–57.
   PubMed Web of Science ®Google Scholar
• Hughes TR, Matron MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, et al. Functional discovery via a compendium of expression profiles. Cell 2000;102:109–26.
   PubMed Web of Science ®Google Scholar
• Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999;402:C47–52.
   PubMed Web of Science ®Google Scholar
• Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME): Toward standards for microarray data. Nat Genet 2001;29:365–71.
   PubMed Web of Science ®Google Scholar
• Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena A, Prantera Crutgeerts P. Proposed classification of patient subgroups in Crohn’s disease. Gastro Int 1992;5:141–54.
   Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer S, Irvine E, et al. A simple classification of Crohn’s disease: Report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6: 8–15.
   Google Scholar
• Bataille F, Klebl F, Rummele P, Straub RH, Wild P, Scholmerich J, et al. Histopathological parameters as predictors for the course of Crohn’s disease. Virchows Arch 2003;443:501–7.
   PubMedGoogle Scholar
• Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, et al. The Molecular Classification of the Clinical Manifestations of Crohn’s disease. Gastroenterology 2002;122:854–66.
   Google Scholar
• Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NHH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95: 359–67.
   Google Scholar
• Lousi E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classification: Changing pattern over the course of the disease. Gut 2001;49:777–82.
   Google Scholar
• Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, et al. CARD15 genetic variation in a Quebec population: Prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74–83.
   PubMed Web of Science ®Google Scholar
• Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: A cohort study. Lancet 2002;359:1661–5.
   PubMed Web of Science ®Google Scholar
• Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 2003;9:281–9.
   PubMed Web of Science ®Google Scholar
• Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, et al. Crohn’s disease and the NOD2 gene: A role for paneth cells. Gastroenterology 2003;125:47–57.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, et al. Expression of NOD2 in Paneth cells: A possible link to Crohn’s ileitis. Gut 2003;52:1591–7.
   PubMed Web of Science ®Google Scholar
• Tomer G, Ceballos C, Conceptcion E, Benkov KJ. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn’s disease. Am J Gastroenterol 2003;98:2479–84.
   PubMedGoogle Scholar
• Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Pena AS. CARD15 gene and the classification of Crohn’s disease. Immunogenetics 2002;54: 59–61.
   Google Scholar
• Radlmayr M, Torok HP, Martin K, Folwaczny C. The c- insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology 2002;122:2091–2.
   PubMed Web of Science ®Google Scholar
• Vavassori P, Borgiani P, D’Apice MR, De Negris F, Del Vecchio Blanco G, Monteleone I, et al. 3020insC mutation within the NOD2 gene in Crohn’s disease: Frequency and association with clinical pattern in an Italian population. Dig Liver Dis 2002;34: 153.
   Google Scholar
• Schreiber S, Hampe J, Eickhoff H, Lehrach H. Functional genomics in gastroenterology. Gut 2000;47:601–7.
   PubMedGoogle Scholar
• Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997;94:2150–5.
   PubMed Web of Science ®Google Scholar
• Sadler TW. Langman’s medical embryology. Baltimore: Williams and Wilkins; 1985.
   Google Scholar
• Bufill JA. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779–88.
   PubMed Web of Science ®Google Scholar
• Pocard M, Salmon RJ, Muleris M, Remvikos Y, Bara J, Dutrillaoux B, et al. Deux colons – deux cancers? Adeno- carcinomes coliques proximal ou distal: Arguments en faveur d’une cancerogenese distincte. Bull Cancer 1995;82:10–21.
   PubMedGoogle Scholar
• Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 1997;15:302–11.
   PubMed Web of Science ®Google Scholar
• Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003;12:755–62.
   PubMed Web of Science ®Google Scholar
• Anderle P, Rakhmanova V, Woodford K, Zerangue N, Sadee W. Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines. Pharm Res 2003;20: 3–15.
   Google Scholar
• Tadjali M, Seidelin JB, Olsen J, Troelsen J. Transcriptome changes during intestinal cell differentiation. Biochim Biophys Acta 2002;1589:160–7.
   PubMedGoogle Scholar
• MizoguchI E, Xavier RJ, Reinecker H-C, Uchino H, Bhan AK, Podolsky DK, et al. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology 2003;125:148–61.
   Google Scholar
• Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, et al. A concise guide to cDNA microarray analysis. Biotechniques 2000;29:548–62.
   PubMed Web of Science ®Google Scholar
• Kerr MK, Churchill GA. Statistical design and the analysis of gene expression microarray data. Genet Res 2001;77:123–8.
   PubMed Web of Science ®Google Scholar
• Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. J Comput Biol 2000;7:819–37.
   Google Scholar
• Yu J, Othman MI, Farjo R, Zareparsi S, MacNee SP, Yoshida S, et al. Evaluation and optimization of procedures for target labeling and hybridization of cDNA microarrays. Mol Vis 2002;26:130–7.
   Google Scholar
• Pellis L, Franssen-van Hal NL, Burema J, Keijer J. The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 2003;16:99–106.
   PubMedGoogle Scholar
• Ogawa H, Fukushima K, Naito H, et al. Increased expression of HIP/HAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 2003;9:162–70.
   PubMed Web of Science ®Google Scholar
• Fukushima K, Ogawa H, Takahashi K, Naito H, Funayama Y, Kitayama T, et al. Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand J Gastroenterol 2003;38:626–34.
   PubMed Web of Science ®Google Scholar
• Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, Madara JL, et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 2003;171:3668–74.
   Google Scholar
• Wang RF, Beggs ML, Robertson LH, Cerniglia CE. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples. FEMS Microbiol Lett 2002;213:175–82.
   PubMed Web of Science ®Google Scholar
• Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B. Library on a slide for bacterial comparative genomics. BMC Microbiology 2004;4:12.
   PubMedGoogle Scholar
• Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000;4:1–11.
   Google Scholar
• Lawrence IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn’s disease: Distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10:445–56.
   Google Scholar
• Uthoff SM, Eichenberger MR, Lewis RK, Fox MP, Hamilton CJ, McAuliffe TL, et al. Identification of candidate genes in ulcerative colitis and Crohn’s disease using cDNA array technology. Int J Oncol 2001;19:803–10.
   PubMed Web of Science ®Google Scholar
• Dieckgraefe BK, Crimmins DL, Landt V, Houchen C, Anant S, Porche-Sorbet R, et al. Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha upregulation, processing, and antiapoptotic activity. J Invest Med 2002;50:421–34.
   Google Scholar
• Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: Screening by DNA microarrays. Inflamm Bowel Dis 2004;10:1–14.
   PubMed Web of Science ®Google Scholar
• Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, et al. Regulation of IL-8 and IL-1β expression in Crohn’s disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004;doi:10.1093/hmg/ddh182.
   Google Scholar
• Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, et al. Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes. Gastroenterology 2004;127:26–40.
   PubMed Web of Science ®Google Scholar
• Barcelo-Batllori S, Andre M, Servis C, Levy N, Takikawa O, Michetti P, et al. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: Implications for inflammatory bowel diseases. Proteomics 2002;2:551–60.
   Google Scholar
• Gershon D. Proteomics technologies: Probing the proteome. Nature 2003;424:581–7.
   Web of Science ®Google Scholar
• Shinozaki S, Nakamura T, Iimura M, Kato Y, Iizuka B, Kobayashi M, et al. Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut 2001;48:623–9.
   PubMed Web of Science ®Google Scholar
• Hagiwara K, Yamaguchi A, Tsuchiya N, Kitamura S, Iwadare J, Sahara R, et al. Identification of genes upregulated in the inflamed colonic lesions of Crohn’s disease. Biochem Biophys Res Commun 2001;283:130–5.
   PubMedGoogle Scholar
• Nielsen FC. The human genome and gene expression. Ugeskr Læger 2003;165:773–6.
   PubMedGoogle Scholar
• Grohmann U, Fallarino F, Silla S, Bianchi R, Belladonna ML, Vacca C, et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 2001;166:277–83.
   PubMed Web of Science ®Google Scholar
• Kamarainen M, Heiskala K, Knuutila S, Heiskala M, Winqvist O, Andersson LC. RELP, a novel human REG- like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol 2003; 163:11–20.
   PubMed Web of Science ®Google Scholar
• Vozenin-Brotons MC, Milliat F, Linard C, Strup C, Francois A, Sabourin JC, et al. Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res 2004;161:299–311.
   Google Scholar
• Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002;21:4855–62.
   PubMed Web of Science ®Google Scholar
• Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic, proteomic, and tissue array profiling. Cancer Res 2003;63: 5243–50.
   PubMed Web of Science ®Google Scholar
• Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, et al. Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins. Cancer Res 2001;61:7585–93.
   PubMed Web of Science ®Google Scholar
• Nam MJ, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach CE, Zhao R, et al. Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin Cterminal hydrolase L3. Proteomics 2003;3:2108–15.
   PubMed Web of Science ®Google Scholar
• Svrcek M, Jourdan F, Sebbagh N, Couvelard A, Chatelain D, Mourra N, et al. Immunohistochemical analysis of adenocarcinoma of the small intestine: A tissue microarray study. J Clin Pathol 2003;56:898–903.
   PubMedGoogle Scholar
• Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, et al. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003;107:896–902.
   PubMedGoogle Scholar
• Meunier JC. Utilizing functional genomics to identify new pain treatments: The example of nociceptin. Am J Pharma- cogenom 2003;3:117–30.
   PubMedGoogle Scholar
• Peterson RL, Wang L, Albert L, Marchese E, Erickson J, Wong A, et al. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. Pharmacogenomics J 2002;2:383–99.
   PubMedGoogle Scholar
• Nakajima A, Wada K, Katayama K, Saubermann L, Osawa E, Nagase H, et al. Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice. J Gastroenterol 2002;37 Suppl 14:62–6.
   PubMedGoogle Scholar
• King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: Promise and pitfalls. JAMA 2001;286: 2280–8.
   PubMed Web of Science ®Google Scholar
• Ntzani EE, Ioannidis JPA. Predictive ability of DNA microarrays for cancer outcomes and correlates: An empirical assessment. Lancet 2003;362:1439–44.
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. Natl Cancer Inst 2004;96:353–6.
   Google Scholar
• Kemmner W, Roefzaad C, Haensch W, Schlag PM. Glyco- syltransferase expression in human colonic tissue examined by oligonucleotide arrays. Biochim Biophys Acta 2003;1621:272–9.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002;62:4427–33.
   Google Scholar
• Moreau Y, Aerts S, De Moor B, De Strooper B, Dabrowski M. Comparison and meta-analysis of microarray data: From the bench to the computer desk. Trends Genet 2003;19: 570–7.
   Google Scholar
• Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, Gurbuz Y, et al. A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genom 2004;16:361–70.
   PubMed Web of Science ®Google Scholar
• Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, et al. Medical applications of microarray technologies: A regulatory science perspective. Nat Genet 2002;32 Suppl:474–9.
   Google Scholar